Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Government
Corporate News
Managed Health Care
Commodities & Futures
Natural Disaster
Executive Activities
Infectious Disease
Science
Table bottom

Cancer & Oncolgy
Today Huntsman Cancer Foundation (HCF) announced that several individuals and business organizations have committed a total of $40 million to support a proposed major building expansion of Huntsman Cancer Institute (HCI) at the University of Utah...
PR Newswire, 10:38pm ET



A new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit (AWV) between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV....
PR Newswire, 11:23am ET

Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids....
PR Newswire, 11:08am ET

OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that Celgene has notified OncoMed that due to strategic product...
GlobeNewswire, 8:08am ET

Array BioPharma Inc. (NASDAQ: ARRY) today announced that the European Commission (EC) has approved BRAFTOVI® in combination with MEKTOVI® for the treatment of adult patients with unresectable or metastatic melanoma with a BRAFV600 mutation, as...
PR Newswire, 2:08pm ET

--- EU approval is based on Phase 3 COLUMBUS trial that demonstrated 14.9 months median progression-free survival and 33.6 months median overall survival versus vemurafenib monotherapy with 7.3 and 16.9 months, respectively - Pierre Fabre...
BusinessWire, 1:28pm ET

We live in an era of information overload, frequently confusing and contradictory. The challenge and difficult task of evaluating and understanding available treatment options for prostate cancer is not immune to this quandary....
PR Newswire, 9:28am ET

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A., known as MSD outside the United...
PR Newswire, 8:08am ET

Researchers and physicians in the GW Cancer Center are targeting health issues that hit close to home. As the center sets its sights on becoming a nationally recognized research hub, officials said researchers and physicians will focus on...
University Wire, 7:23am ET

The global infusion pump market is expected to grow significantly from USD 9,210 million in 2017 to USD 14,500 million in 2024, at a CAGR of 6.6% from 2018 to 2024. The growth in the market is attributed to the growing incidence of chronic...
GlobeNewswire, 5:38am ET

-- The collaboration between St. Jude and Tessa aims to advance cellular immunotherapy treatments for childhood cancer -- St. Jude and Tessa will pioneer a novel approach to pediatric high grade gliomas, aggressive brain cancers in...
PR Newswire, 7:33pm ET

I begin by acknowledging the traditional owners of the land on which we meet, the Yugambeh people of south-east Queensland. I pay my respects to your Elders, past and present, who have kept law and language and culture strong in...
Euclid Tenders Info, 6:43pm ET

According to the market research report released by Technavio, the global optical imaging market is expected to accelerate at a CAGR of more than 8% during the forecast period. The increasing market penetration of digital...
BusinessWire, 5:58pm ET

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 1:10 p.m. EDT...
BusinessWire, 4:18pm ET

Digital Landscape: Breast Cancer Summary"Digital Landscape: Breast Cancer", analyzes digital activities undertaken by pharma in support of therapies for Breast Cancer. Read the full report: https://www.reportlinker.com/p05568478...
PR Newswire, 3:53pm ET

In-Shape Health Clubs, California's top destination for fitness and recreation, today announced its goal to raise $150,000 for cancer research in the month of October for its 4th annual Fight Cancer campaign....
PR Newswire, 3:33pm ET

Wendy Demark-Wahnefried, Ph.D., R.D.Researchers with the University of Alabama at Birmingham have received a five-year $11.7 million grant from the NIH and National Cancer Institute to test effective and scalable diet and exercise interventions...
University Wire, 3:13pm ET

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that Noridian GBA, a Medicare Administrative Contractor (MAC), has issued a draft local coverage determination (LCD) for use of the Decipher® Prostate...
PR Newswire, 3:03pm ET

Global Bone Metastasis Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Global Bone Metastasis industry. The report provides a basic overview of the industry including definitions,...
Heraldkeeper, 1:18pm ET

Crocs, Inc. (NASDAQ: CROX), a global leader in innovative casual footwear for women, men and children, today announced that it has partnered with Susan G. Komen(R), the world's leading breast cancer organization, to support...
BusinessWire, 1:18pm ET

1-20 of 187
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.